Introduction
============

Endothelial cells (ECs) are highly responsive to fluid shear stress from blood flow, activating a large number of signaling and gene expression pathways depending on the magnitude, pulsatility, and direction of the flow ([@bib12]; [@bib7]; [@bib5]). These signals are crucial for embryonic development, including the rearrangement of the primitive vascular plexus into a vascular tree ([@bib43]), development of the heart ([@bib33]), and several aspects of adult physiology. Increases or decreases in fluid shear stress magnitude induce, respectively, vasorelaxation or constriction on short time scales, and outward or inward vessel remodeling on longer time scales ([@bib41]; [@bib60]; [@bib15]). Furthermore, high laminar or pulsatile fluid flow inhibits proliferation and activation of inflammatory pathways in the endothelium to stabilize the vasculature ([@bib46]; [@bib65]; [@bib51]; [@bib25]). In contrast, low, oscillatory, or multidirectional fluid shear stress (termed disturbed flow) activates inflammatory pathways including NF-κB and JNK ([@bib11]; [@bib56]; [@bib29]; [@bib28]; [@bib52]). These pathways stimulate expression of cytokines and adhesion receptors such as MCP-1, VCAM-1, and ICAM-1 that mediate recruitment of leukocytes. This differential activation of pro- versus anti-inflammatory pathways is believed to underlie the preferential occurrence of atherosclerotic plaque at regions of artery branching, bifurcation, and high curvature that have lower flow and complex, multidirectional flow patterns.

Previous work identified a complex of proteins at cell--cell junctions, consisting of PECAM-1, VE-cadherin (VEcad), and VEGFR2, as an important, endothelial-specific flow sensor ([@bib67]). PECAM-1 is an Ig family homophilic cell adhesion receptor that localizes to endothelial cell--cell contacts and contributes to junctional integrity and movement of leukocytes across the endothelium ([@bib61]). It is dispensable for embryonic development but is required for flow-induced vessel remodeling and contributes to inflammatory activation at regions of disturbed flow and atherosclerosis ([@bib26]; [@bib32]; [@bib63]). Development of a molecular force sensor showed that application of flow to ECs induces piconewton force across PECAM-1 ([@bib9]), while direct application of force to PECAM-1 triggers some of the same pathways that are activated by flow ([@bib57]; [@bib67]). Thus, PECAM-1 appears to be a true mechanotransducer for fluid shear stress. VEcad is a classical type II cadherin that localizes to endothelial cell junctions and is essential for vascular development and integrity ([@bib68]). Its deletion is embryonic lethal in part due to a defect in vascular endothelial growth factor receptor (VEGFR) signaling, which indicates an interaction between these receptors ([@bib4]). It is also essential for ligand-independent activation of VEGFR2 by flow, though the nature of this requirement is poorly understood ([@bib67]). VEcad does not show any increase in tension after flow ([@bib9]), does not activate relevant pathways when tension is applied through magnetic beads ([@bib67]), and thus does not directly transduce mechanical forces. Yet, it is essential for downstream signaling when tension is applied to PECAM-1 ([@bib67]). VEcad is not strictly required for endothelial cell junction formation per se, since its loss results in up-regulation of N-cadherin (Ncad; [@bib49]; [@bib24]), which indicates that flow signaling is a VEcad-specific function.

Our current model for flow signaling through the junctional complex is that force on PECAM-1 triggers activation of a Src family kinase (SFK), probably Fyn ([@bib6]), which phosphorylates and activates VEGFR2 in the absence of ligand. Activated VEGFR2 triggers multiple downstream pathways including PI 3-kinase ([@bib35]), which stimulates conversion of integrins to the high-affinity conformation, binding to extracellular matrix and downstream signaling ([@bib55]). Integrin signaling mediates alignment of the ECs in the direction of flow, and, depending on the extracellular matrix, the activation or suppression of inflammatory pathways ([@bib54], [@bib55], [@bib56]; [@bib29], [@bib30]). Stimulation of PI 3-kinase though this pathway is also important for activation of eNOS and vasorelaxation ([@bib20]). In laminar flow, inflammatory activation is transient, followed by alignment of the cells in the direction of flow, down-regulation of inflammatory pathways, and up-regulation of anti-inflammatory pathways ([@bib34]; [@bib30]; [@bib70]). In contrast, in disturbed flow, cells do not align and inflammatory activation is sustained ([@bib34]; [@bib8]; [@bib19]; [@bib70]).

In this study, we set out to understand VEcad's precise role in shear stress signaling. We took advantage of the fact that its close paralogue Ncad can mediate endothelial cell--cell junctions but not flow signaling. VEcad/Ncad chimeras identified the transmembrane domain (TMD) as the critical VE-specific region required for flow signaling. Subsequent work showed that this region binds VEGFR2 and -3, and demonstrated a role for VEGFR3 in flow signaling in vitro and in vivo.

Results
=======

The VEcad TMD is required for shear mechanotransduction
-------------------------------------------------------

To confirm that VEcad is unique in its involvement in shear stress signaling and to validate the experimental system, VEcad-null endothelial cells (VEcad^−/−^; [@bib4]) were infected with lentivirus coding for with either VEcad or Ncad. Cells showing equal expression were selected ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201408103/DC1){#supp1}) and used for subsequent studies. Both cadherins localized well to cell--cell borders and bound β-catenin similarly (Fig. S1 B). To assess flow responsiveness, we examined alignment after 18 h of flow at 12 dynes/cm^2^ ([Fig. 1 A](#fig1){ref-type="fig"}). Only VEcad rescued the alignment defect of VEcad^−/−^ cells ([Fig. 1 B](#fig1){ref-type="fig"}). Next, we used this assay to examine chimeras with different regions of VEcad and Ncad (see [Fig. 1 C](#fig1){ref-type="fig"} for domain organization). All of the chimeric cadherins also localized well to cell--cell contacts and bound β-catenin (Fig. S1, B and C; and data not depicted). The first round of experiments showed that a segment comprising the extracellular domain (ECD) and TMD of VEcad conferred flow sensitivity, whereas the cytoplasmic domain did not ([Fig. 1 D](#fig1){ref-type="fig"}). Further dissection of the extracellular/transmembrane regions showed that the transmembrane sequence of VEcad fully rescued alignment when inserted into Ncad (Ncad^VE-TMD^; [Fig. 1 D](#fig1){ref-type="fig"}). Conversely, substitution of the Ncad TMD into VEcad (VEcad^N-TMD^) completely abrogated alignment ([Fig. 1 E](#fig1){ref-type="fig"}).

![**Using cadherin chimeras to map VEcad-specific functional domains.** (A) Endothelial cells orient into the direction of flow. Shown is an example of shear-induced alignment in HUVECs after exposure to 12 dynes/cm^2^ laminar shear stress for 16 h in a parallel plate flow chamber. Slides were fixed and stained for VEcad, phalloidin--Alexa Fluor 647, and Hoechst. Bar, 30 µm. (B) VEcad-null (VEcad^−/−^) endothelial cells were reconstituted with human VEcad or Ncad, then exposed to 12 dynes/cm^2^ laminar shear stress for 16 h. Cell alignment in the direction of flow (±23°) was quantified. Values are means ± SEM (error bars), *n* ≥ 3. (C) Domain organization of VEcad and Ncad. Each cadherin has an extracellular domain containing five cadherin repeats (CA1--5), a single-pass TMD, and an intracellular domain (ICD) including p120 and β-catenin binding sites. A Flag tag was also added to each construct. (D) VEcad^−/−^ cells reconstituted with WT or chimeric VEcad/Ncad were assayed for alignment as in B. (E) VEcad^−/−^ cells were reconstituted with mouse, WT VEcad, or VEcad containing the human Ncad-TMD (VEcad^N-TMD^). Alignment in flow was analyzed as in A. Values are means ± SEM (error bars), *n* ≥ 3. \*, P \< 0.05 significance to VEcad^−/−^ by one-way analysis of variance (ANOVA). The broken lines in each graph indicate random alignment.](JCB_201408103_Fig1){#fig1}

We next examined additional flow responses through the junctional complex. VEcad was previously reported to be downstream of shear-induced SFK activation but upstream of VEGFR2 activation ([@bib67]). We first confirmed this using VEcad knockdown in human umbilical cord endothelial cells (HUVECs). Cells expressing control or anti-VEcad shRNA were treated with laminar shear stress for 1 min. Shear stress activated SFK in both cells but VEGFR2 was only activated in control cells ([Fig. 2 A](#fig2){ref-type="fig"}). We then tested VEGFR2 transactivation in our chimeric cadherin-expressing cells. Onset of laminar flow transactivated VEGFR2 in cells expressing wild-type (WT) VEcad or Ncad^VE-TMD^, but not Ncad or VEcad^N-TMD^ ([Fig. 2 B](#fig2){ref-type="fig"}). Phosphorylation of the PI 3-kinase p85 subunit by onset of flow showed similar characteristics ([Fig. 2 C](#fig2){ref-type="fig"}). Together, these data show that the VEcad TMD is the critical VE-specific region required for responses to fluid shear stress through the junctional complex.

![**VEcad TMD in flow signaling.** (A) Requirement for VEcad. HUVECS were infected with scrambled or anti-VEcad shRNA-containing lentiviruses then subjected to 12 dynes/cm^2^ laminar shear for 1 min. Activation of SFKs (SFK^pY416^, ∼55 kD) and VEGFR2 (VEGFR2^pY1175^, ∼250 and 220 kD) were assayed by immunoblotting, with actin as a loading control. (B) VEcad TMD requirement for VEGFR activation. VEcad^−/−^ cells reconstituted with VEcad^WT^, Ncad^VE-TMD^, Ncad^WT^, and VEcad^N-TMD^ were subjected to laminar shear stress for 1 min, then VEGFR2 activation was assayed as in A. (C) VEcad requirement for PI3K signaling. Cells were subjected to laminar shear stress, then p85 immunoprecipitated and immunoblotted with anti-p85^pY458^ antibody. Values beneath each panel indicate phosphorylation relative to cells without flow, quantified by densitometry with total p85 serving as a loading control. For all panels, values are means ± SEM, *n* = 3. IB, immunoblotting.](JCB_201408103R_Fig2){#fig2}

The VEcad TMD confers binding to VEGFR2 and VEGFR3
--------------------------------------------------

We next addressed how the VEcad TMD might contribute to flow signaling. We previously hypothesized that VEcad functioned as an adapter in this pathway ([@bib67]). Therefore, we tested for protein interactions specific to this sequence. Immunoprecipitates from both Ncad^VE-TMD^ chimera and Ncad were examined by SDS-PAGE and silver staining. A weak band at 190 kD in the Ncad^VE-TMD^ chimera and absent in the Ncad immunoprecipitates was cut from the gel and subjected to mass spectrometry protein identification. The band contained multiple peptides from VEGFR3, a close homologue of VEGFR2 ([Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201408103/DC1){#supp2}). To confirm this result, we immunoprecipitated either endogenous VEcad or Ncad from HUVEC lysates. An equivalent amount of β-catenin was detected in both immunoprecipitates, which indicates that the same amount of each cadherin was isolated ([@bib49]). However, VEGFR3 immunoprecipitated with VEcad but not Ncad ([Fig. 3 A](#fig3){ref-type="fig"}). This interaction was constitutive, as no increase was observed in response to flow (Fig. S2 B). To further test the specificity of the interaction, immunoprecipitates for Flag-tagged VEcad and Ncad, and the Ncad^VE-TMD^ and VEcad^N-TMD^ chimeras, were probed for VEGFR3. Both VEcad and Ncad^VE-TMD^ bound VEGFR3 at significantly greater levels than Ncad and VEcad^N-TMD^, which indicates that the interaction is primarily driven by the VE-TMD ([Fig. 3 B](#fig3){ref-type="fig"}). The VE-TMD--containing constructs also coimmunoprecipitated with VEGFR2 (Fig. S2 C), although, in HUVEC lysates, this interaction appeared weaker than for VEGFR3. Thus, the VEcad TMD mediates the interaction with VEGFRs.

![**Interaction of VEGFRs with VEcad through the TMDs.** (A) Coimmunoprecipitation of endogenous VEcad with VEGFR3. Lysates from confluent HUVECs were immunoprecipitated for VEcad, Ncad, or with control antibody and immunoblotted for VEGFR3. β-Catenin was used as a loading control. (B) Dependence on the TMD. VEGFR3-GFP was cotransfected with Flag-tagged cadherins into Cos7 cells, then cells were lysed, immunoprecipitated for Flag, and eluted with 3×-Flag peptide. Eluted proteins were analyzed by immunoblotting as indicated. Relative binding was measured by densitometry, and quantification is shown in the graph below. Values are means ± SEM (error bars), *n* = 4. (C) Direct binding. HA-tagged VEGFR or PDGFRβ and Flag-tagged cadherin TMD constructs are depicted in the top panel. Proteins were purified, mixed, and immunoprecipitated with anti-HA--coupled Protein A/G agarose. Immunoprecipitates were analyzed by immunoblotting for Flag and HA. Results in A--C are representative of at least three independent experiments. IB, immunoblotting.](JCB_201408103R_Fig3){#fig3}

We also attempted to validate this interaction by colocalization to endothelial cell--cell junctions. However, the results were hard to interpret, probably due to cell geometry that causes many membrane proteins to appear brighter at cell--cell contacts. We therefore examined colocalization of VEGFR3-GFP and VEcad by plating VEcad^WT^ and VEcad^N-TMD^ cells on slides coated with immobilized VEcad extracellular domain-Fc. Cells spread on these surfaces and organized the cadherins into adhesive structures on the coverslip surface ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201408103/DC1){#supp3}), similar to published results ([@bib23]), whereas cell adhesion to control slides was negligible (not depicted). VEGFR3-GFP showed distinct colocalization with VEcad^WT^ compared with VEcad^N-TMD^, providing further evidence for their interaction in cells.

Direct binding between TMDs
---------------------------

We next addressed whether the VEcad--VEGFR interaction was direct. For this purpose, we developed constructs containing the cadherin and VEGFR TMDs with short intracellular and extracellular tags for expression and purification from bacteria (sequences are provided in the Materials and methods). The recombinant VE- and N-TMD constructs were Flag-tagged, whereas the VEGFR2- and VEGFR3-TMDs were HA-tagged ([Fig. 3 C](#fig3){ref-type="fig"}, top). These peptides were purified in a nondenaturing CHAPS buffer, mixed, and incubated at 37°C, then immunoprecipitated with anti-HA beads. Blotting for Flag-tagged cadherin TMDs revealed that the VE-TMD bound both VEGFR2-TMD and VEGFR3-TMD but not the related PDGFRβ-TMD, whereas the N-TMD showed only background binding ([Fig. 3 C](#fig3){ref-type="fig"}, bottom). These results show that the VEcad and VEGFR complexes bind directly, and, moreover, that VEGFR2 and -3 show similar affinity.

The VEcad--VEGFR complex promotes shear-mediated VEGFR transactivation
----------------------------------------------------------------------

Flow induces ligand-independent activation of VEGFR2, which is required for subsequent activation of PI3K and integrins ([@bib35]; [@bib67]). We therefore tested whether flow also transactivates VEGFR3. To allow a direct comparison in these experiments, we used an antibody that recognizes phosphorylated Y1054/9 in the kinase domain activation loops, a site that is highly conserved between VEGFR2 and -3. Thus, anti-pY1054/9 does not discriminate between the two paralogues. HUVECs were subjected to short-term laminar shear and Y1054/9 phosphorylation was analyzed. Both VEGFR2 and VEGFR3 were initially activated similarly, but VEGFR3 exhibited a more sustained response ([Fig. 4 A](#fig4){ref-type="fig"}). The activation kinetics of each receptor were confirmed with additional phospho-VEGFR antibodies, anti-VEGFR2^pY1175^ and anti-VEGFR3^pY1230^, which recognize sites commonly phosphorylated in response to ligand ([Fig. 4 A](#fig4){ref-type="fig"}). Thus, VEGFR3, like VEGFR2, shows activation by flow in the absence of ligand.

![**VEcad TMD in shear-mediated VEGFR2 and VEGFR3 activation.** (A) VEGFR activation. HUVECs exposed to 12 dynes/cm^2^ laminar shear for the indicated times were immunoblotted with the indicated antibodies. The upper band on the anti-VEGFR2/3^pY1054/9^ blot is active VEGFR2; the lower band is active VEGFR3 (arrowheads). IB, immunoblotting. (B) Dependence on TMD. VEcad^−/−^, VEcad^WT^, and VEcad^ΔTMD^ cells were subjected to shear stress, then lysed and immunoblotted as in A. The anti-VEGFR^pY1230^ blots were quantified by densitometry of the ∼120-kD band with actin serving as a loading control. Values are means ± SEM (error bars), *n* ≥ 3. Yellow lines mark boundaries between cell types.](JCB_201408103_Fig4){#fig4}

Next, we tested the dependence of VEGFR activation on the VEcad TMD by examining VEcad^−/−^, VEcad^WT^, and VEcad^N-TMD^ cells. Shear-mediated activation of VEGFR2 and -3 required the VEcad TMD ([Fig. 4 B](#fig4){ref-type="fig"}). Additionally, we assayed effects of the VEcad TMD on VEGFR2 activation in response to its ligand, VEGF-A165. WT VEcad enhanced VEGFR2^pY1175^ activation by VEGF-A above the levels seen in VEcad^−/−^ cells ([Fig. S4 A](http://www.jcb.org/cgi/content/full/jcb.201408103/DC1){#supp4}); VEcad^N-TMD^ enhanced VEGFR2 activation nearly as effectively as WT VEcad at early times of stimulation, though VEGFR2 activation decreased faster than with WT. These data indicate that the TMD interaction is not required for the initial enhancement of VEGF responses by VEcad but that it influences maintenance of the signal at later times. Similar results were obtained in HUVEC shRNA/rescue experiments (Fig. S4 B).

VEGFRs display functional overlap and dosage sensitivity
--------------------------------------------------------

These results raise questions about the relative contribution of VEGFR2 and -3 in flow signaling. Published functional analyses ([@bib35]; [@bib67]) used chemical inhibitors of tyrosine kinase activity that do not discriminate between these paralogues ([@bib18]), thus, it is unclear to what extent VEGFR2 and -3 have unique effectors, and function additively or redundantly. VEGFR2 is required for shear-mediated activation of PI3K and integrins, and for cell alignment. We therefore performed shear experiments with human ECs treated with siRNAs against each VEGFR, or both ([Fig. 5 A](#fig5){ref-type="fig"}). Depletion of the individual VEGFRs partially decreased phosphorylation of PI3K and had a slight effect on Akt activation, as determined by immunoblotting pS473 ([@bib71]), whereas depletion of both strongly inhibited it ([Fig. 5, B and C](#fig5){ref-type="fig"}). Therefore, VEGFR2 and -3 both contribute to shear-mediated PI3K-Akt signaling.

![**VEGFRs in PI 3-kinase and integrin activation.** (A) VEGFR knockdown. HUVECs transfected with the indicated siRNAs for 72 h were analyzed for VEGFR expression by immunoblotting. Three independent experiments gave similar results. (B) PI3K signaling. HUVECs transfected as in A were subjected to shear stress and p85 was immunoprecipitated. Samples were then analyzed by immunoblotting and densitometry as in [Fig 2 C](#fig2){ref-type="fig"}. Values are means ± SEM, *n* = 4. (C) Akt signaling. siRNA-treated HUVECs were subjected to laminar shear stress for the indicated times and lysates were analyzed by immunoblotting with the indicated antibodies to determine Akt activity. Results were quantified by densitometry, with actin serving as a loading control. Values are means ± SEM (error bars), *n* = 3. \*, P \< 0.05 relative to unstimulated cells by two-way ANOVA. IB, immunoblotting.](JCB_201408103_Fig5){#fig5}

When alignment after 16 h of flow was assayed, depletion of either VEGFR2 or VEGFR3 substantially inhibited alignment, whereas depletion of both receptors slightly increased the degree of inhibition ([Fig. 6](#fig6){ref-type="fig"}). Next, depletion was rescued using adenoviruses containing mCherry (control, −), VEGFR2-GFP, or VEGFR3-GFP to express each paralogue at levels close to endogenous ([Fig. S5 A](http://www.jcb.org/cgi/content/full/jcb.201408103/DC1){#supp5}). VEGFR2-GFP rescued not only its own knockdown but also knockdown of VEGFR3; similarly, VEGFR3-GFP rescued both its own and VEGFR2 knockdown ([Fig. 6](#fig6){ref-type="fig"}). These results show that while both VEGFR2 and VEGFR3 contribute to flow signaling, they are functionally redundant. Different downstream pathways show different dose requirements, but the effects appear to be essentially additive. In support of this conclusion, we estimated the ratio of endogenous VEGFR2/VEGFR3 in HUVEC to be ∼2:1 by calibrating anti-VEGFR antibodies with VEGFR2-GFP and VEGFR3-GFP constructs, with anti-GFP as a reference antibody (Fig. S5 B).

![**VEGFRs in shear-induced alignment.** HUVECs were transfected with siRNAs as in [Fig 4 A](#fig4){ref-type="fig"} before being infected with mCherry (−) or VEGFR-expressing adenoviruses as indicated. Cells were subject to 12 dynes/cm^2^ laminar shear stress for 16 h. Then, fixed cell alignment was quantified as in [Fig 1 B](#fig1){ref-type="fig"}. Values are means ± SEM (error bars), *n* ≥ 3. \*, P \< 0.05 relative to siScramble by one-way ANOVA. The broken line indicates random alignment, as in [Fig. 1.](#fig1){ref-type="fig"}](JCB_201408103R_Fig6){#fig6}

VEcad-VEGFRs in inflammatory flow signaling
-------------------------------------------

The junctional complex is required for flow stimulation of inflammatory pathways that lead to leukocyte recruitment ([@bib42]), a key step in initiation of atherosclerosis. Activation of fibronectin-binding integrins and subsequent activation of NF-κB are critical components of this response ([@bib54]; [@bib42]). We therefore tested the role of the VEGFRs in these events. Integrin activation was assayed by incubating cells with a recombinant, GST-tagged fibronectin fragment consisting of the ninth to eleventh FN repeats (GST-FN9-11). The flow-induced increase in GST-FN9-11 binding was completely blocked by depletion of either VEGFR ([Fig. 7 A](#fig7){ref-type="fig"}). Maximal activation of the integrins with Mn^2+^ completely reversed the effects of VEGFR depletion, ruling out loss of integrin expression or surface localization. Thus, both VEGFR2 and VEGFR3 are required for shear-induced integrin activation. We also assayed events downstream of NF-κB. Up-regulation of the leukocyte adhesion receptor VCAM-1 in response to oscillatory shear stress (OSS) was strongly inhibited by depletion of either VEGFR2 or -3 ([Fig. 7 B](#fig7){ref-type="fig"}). Consistent with this result, stimulation of monocyte adhesion by OSS was also almost completely inhibited by siRNA against VEGFR2 or VEGFR3 individually ([Fig. 7 C](#fig7){ref-type="fig"}).

![**The VEcad--VEGFR complex in inflammatory signaling.** (A) Integrin activation. HUVECs transfected with the indicated siRNA were left untreated or exposed to 15 min of laminar shear stress. After shear stress, slides were incubated with GST-FN9-11. Mn^2+^ was used as a positive control to maximally active the integrins. Bound GST-FN9-11 was detected by immunoblotting with anti-GST and quantified by densitometry. Graphed values are means ± SEM (error bars; *n* = 4) after normalization to Mn^2+^. \*, P \< 0.05 using a Student's *t* test. The arrowhead indicates full-length, active GST-FN9-11 protein. (B) VCAM-1 induction. siRNA-transfected cells were exposed to OSS for 12--24 h. Lysates were collected and immunoblotted with anti--VCAM-1 and anti-actin. Bands were quantified by densitometry and values are expressed as means ± SEM, *n* = 3, relative to the unstimulated condition. (C) Monocyte binding. HUVECs were exposed to OSS as in B for 18 h, then incubated with THP-1 monocytes in HBSS+BSA for 30 min. Slides were washed, fixed, and stained. Bound monocytes were then quantified by fluorescence microscopy. Values are means ± SEM (error bars), *n* = 3, normalized to unstimulated siScrambled. \*, P \< 0.05 using a Student's *t* test. (D) Dependence on TMD. VEcad^WT^ and VEcad^N-TMD^ cells were exposed to OSS for 18 h, then analyzed for VCAM-1 expression and NF-κB p65 activation, with actin as a loading control. Bands were quantified by densitometry. Values are means ± SEM, *n* = 4, relative to unstimulated controls. IB, immunoblotting.](JCB_201408103_Fig7){#fig7}

We then tested the requirement for the VEcad--VEGFR interaction in shear-induced inflammatory signaling by applying OSS to VEcad^WT^ and VEcad^N-TMD^ cells. Oscillatory shear activated NF-κB and up-regulated VCAM-1 in VEcad^WT^ cells but not in VEcad^N-TMD^ cells ([Fig. 7 D](#fig7){ref-type="fig"}). Therefore, the VEGFRs must associate with VEcad in order for endothelial cells to respond to OSS.

VEGFR3 contributes to shear signaling in vivo
---------------------------------------------

Last, we sought to address the role of VEGFR3 in flow signaling in vivo. VEGFR3 is expressed in lymphatic endothelial cells ([@bib38]) and angiogenic endothelium ([@bib39]; [@bib27]; [@bib72]; [@bib64]) but its expression is relatively weak in quiescent adult arteries. We therefore hypothesized that VEGFR3 expression might be correlated with activated endothelium/sites of vascular remodeling. Thus, we first examined VEGFR3 expression in arterial endothelium by qPCR of mRNA isolated from endothelial cell in adult mouse aortas. VEGFR3 expression was easily detected in this assay ([Fig. 8 A](#fig8){ref-type="fig"}). Next, we examined mice in which YFP was knocked into the VEGFR3 locus to generate a VEGFR3 reporter ([@bib3]). Longitudinal sections of aortas from adult mice showed robust YFP expression in the inner curvature of the aortic arch, with weaker expression throughout the rest of the aorta ([Fig. 8 B](#fig8){ref-type="fig"} and data not depicted). No fluorescence was observed in control mice lacking YFP expression. Interestingly, the inner curvature is a site where disturbed flow induces chronic inflammation in WT mice, characterized by the accumulation of fibronectin and VCAM-1 within the intima, which primes the endothelium for development of atherosclerosis in hypercholesterolemia ([@bib13]). To test the role for VEGFR3 in disturbed flow--induced inflammatory activation of the endothelium, we used an inducible VEGFR3 deletion model. Adult male *Cdh5:Cre*,*Vegfr3^lox/lox^*, and WT control mice were treated with tamoxifen to induce VEGFR3 excision ([Fig. 8 B](#fig8){ref-type="fig"}). After 3 wk, VEGFR3 deletion reduced staining for fibronectin ([Fig. 8 D](#fig8){ref-type="fig"}) and VCAM-1 ([Fig. 8 E](#fig8){ref-type="fig"}) in the inner curvature of the aortic arch compared with their WT counterparts. These data show that VEGFR3 contributes to shear-induced inflammatory signaling in vivo.

![**The role of VEGFR3 in the mouse aorta.** (A) VEGFR3 expression in arterial endothelium. Total RNA isolated from the endothelial layer was analyzed by qPCR for the indicated genes. VEcad and VEGFR3 expression are represented as mean fold enrichment of the endothelial preparation over the remaining media ± SEM (error bars) from four aortas. The relative abundance of the medial layer markers SMA and SM22 indicate the purity of endothelial preparations. (B) VEGFR3 reporter. Aortas from adult VEGFR3-driven YFP gene reporter mice were sectioned longitudinally and stained for the YFP reporter and for nuclei using Hoechst staining. IC, inner curvature. Images are representative of five mice from several litters. (C) VEGFR2 iΔEC. Endothelial-specific, inducible VEGFR3 knockout (iΔEC) and WT control mice were treated with tamoxifen, and aortas were removed after 1 wk. Tissue lysates were collected and immunoblotted with the indicated antibodies. IB, immunoblotting. (D and E) Inflammatory markers. VEGFR3 iΔEC and WT control mice were treated with tamoxifen and examined at 3 wk. Aortas were sectioned longitudinally and stained for fibronectin (D) or VCAM-1 (E). Images are representative of 6 mice from two independent experiments. Bars, 100 µm. The ratio of mean fluorescence intensity between the inner and outer curvature was then quantified. Values are means ± SEM (error bars). \*, P \< 0.05. Open circles denote outliers excluded from analysis by Grubbs' test (α = 0.05).](JCB_201408103_Fig8){#fig8}

Discussion
==========

VEcad is structurally and functionally very similar to other classical cadherins but is unique in its contribution to flow sensing by endothelial cells ([@bib67]). In this study, we used Ncad and VEcad chimeras to identify the sequences required for shear stress mechanotransduction. This approach led to the surprising result that the TMD is the critical VEcad-specific sequence. This conclusion is supported by both loss-of-function and gain-of-function constructs, which indicates that in the context of a functional classical cadherin, the TMD is both necessary and sufficient for flow signaling. The VEcad TMD primary sequence contains unique, conserved features distinct from both Ncad and more similar type II cadherins (unpublished data). These results add to the growing literature showing that these previously ignored domains serve as more than just membrane anchors ([@bib1]; [@bib47]; [@bib10]). Recent studies have shown that TMDs determine subcellular distribution, protein clustering, and membrane microdomain localization ([@bib62]; [@bib2]; [@bib14]). Transmembrane protein--protein interactions additionally control the activation status of receptor tyrosine kinases, integrins, and channels ([@bib66]; [@bib16]; [@bib17]; [@bib45]). The role of the VEcad TMD in mechanotransduction thus extends this list in a new direction.

Next, we found that the VEcad TMD mediates binding to VEGFRs 2 and 3, which, based on assays with purified TMD constructs, is direct. VEcad was previously shown to coimmunoprecipitate with VEGFR2, and to modulate VEGFR2 downstream signaling in response to VEGF to decrease Erk and increase PI3K ([@bib4]). VEcad and VEGFR2 were also found to interact in flow signaling, where they coimmunoprecipitate and where VEcad was required for ligand-independent activation of VEGFR2 by flow ([@bib67]). These new data therefore show that the TMDs for VEcad and VEGFR2 mediate their interaction.

The results also identify VEGFR3 as a novel component of the junctional complex. Like VEGFR2, VEGFR3 was activated by the onset of shear stress and signaled through PI3K and integrins in a VEcad-TMD--dependent manner. Knockdown and rescue experiments showed that these VEGFRs are functionally redundant, as each can rescue loss of the other. This feature is unexpected because otherwise VEGFR2 and -3 induce distinct endothelial fates (arterial vs. lymphatic) during development ([@bib53]). This difference may reflect ligand-dependent versus ligand-independent signaling, or may reflect our incomplete understanding of the downstream pathways that mediate these fate decisions. In any case, the data further suggest that what matters in flow signaling is total receptor expression levels. HUVECs in culture express comparable levels of VEGFR2 and -3 (Fig. S5 B). Knockdown experiments showed that depletion of either receptor individually strongly reduced flow-induced integrin activation, cell alignment, and inflammatory activation; had a partial effect on PI3K; and had a weak effect on Akt. However, depletion of both receptors strongly inhibited all of these effector functions. Thus, these differences can be explained simply if different downstream events have different dose requirements.

Finally, we tested a functional role for VEGFR3 in mice in flow-dependent mechanotransduction. VEGFR3 is normally expressed in blood vessels during development and adult angiogenesis but is otherwise low in stable arteries ([@bib27]; [@bib72]; [@bib64]). However, we found that its mRNA was readily detectable in the normal mouse aorta, and a reporter construct was up-regulated at the inner curvature of the aortic arch that is exposed to disturbed shear stress. The subsequent chronic inflammatory activation of the endothelium in these regions "primes" the vessel for development of atherosclerosis under conditions of high cholesterol ([@bib36]). Deletion of VEGFR3 in adult mice reduced inflammatory signaling at this site. No loss of lymphatic vessels was noted after VEGFR3 deletion (unpublished data). Moreover, the circulating levels for VEGF-C, the ligand for VEGFR3, are negligible ([@bib37]), which is consistent with ligand-independent activation. We conclude that VEGFR3 significantly contributes to flow signaling in vivo. Interestingly, others have previously noted that deletion of VEGFR3 during development causes severe vascular abnormalities that are not phenocopied by deletion of the two known VEGFR3 ligands VEGF-C and VEGF-D ([@bib31]). Thus, shear stress--mediated VEGFR3 signaling may also contribute to developmental vascular remodeling.

VEcad was previously placed in a flow signaling pathway downstream of SFKs and upstream of PI3K ([@bib67]). Here we show that VEcad contributes to this pathway through its role as an adaptor for VEGFRs. Interestingly, cadherins are known to indirectly associate with SFKs through catenins ([@bib58]). Because previous reports have shown that VEGFR2 and VEGFR3 transactivation is SFK-dependent and ligand-independent ([@bib35]; [@bib22]), we hypothesize that VEcad could be involved in bringing together SFKs with VEGFRs in order to facilitate the phosphorylation of the latter by the former. In contrast, VEGFR activation by VEGFA~165~ was only modestly dependent on the VEcad-TMD, mainly at later times. The timing of this effect suggests that it may be caused by effects of VEcad on VEGFR trafficking, which is known to control downstream signaling ([@bib40]). However, complete loss of VEcad had a stronger effect on VEGF responses. Other sequences in VEcad therefore appear to contribute to VEGFR signaling in ways that remain to be elucidated. The membrane phosphatase VE-PTP is a good candidate, as it directly binds VEcad and regulates VEGFR signaling ([@bib50]). In summary, these results provide new molecular understanding of how VEcad functions in mechanotransduction. They demonstrate that the VEcad TMD mediates an adapter function through binding to VEGFR TMDs to facilitate ligand-independent transactivation. They also identify VEGFR3 as a component of the junctional mechanosensory complex, and demonstrate an additive relationship between VEGFR2 and -3. Major unanswered questions for future work include elucidating the relationship to PECAM-1 in mechanotransduction and understanding in detail how, and which, SFK members promote VEcad-mediated VEGFR activation.

Materials and methods
=====================

Cloning
-------

Human VEcad, human Ncad, and mouse VEcad cDNAs were used to make C-terminally Flag-tagged chimeras in a modified pBOB lentiviral expression vector. The following amino acid sites were used to make chimeras: VE^1--623^-N^747--906^ (VE^ECD+TMD^); VE^622--784^-N^1--747^ (VE^ICD^); N^1--504^-VE^380--623^-N^747--906^ (VE^CA4-5+TMD^); N^1--504^-VE^383--480^-N^607--906^ (VE^CA4^); N^1--605^-VE^482--622^-N^747--906^ (VE^CA5+TMD^); N^1--717^-VE^595--622^-N^747--906^ (VE^TMD^); and Mm_VE^1--594^-N^717--747^-VE^622--784^ (VE^N-TMD^). Bacterial expression constructs were prepared by annealing oligonucleotides encoding peptide fragments and subcloning into a modified pET expression vector. Human and mouse VEGFR2-GFP and VEGFR3-GFP were cloned into adenoviral and lentiviral, CMV-driven expression vectors using LR clonase (Gateway system; Invitrogen) between pENTR1A and pAd/CMV/V5-DEST or pLenti6/V5-DEST.

Cell culture
------------

VEcad--null embryoid body--derived endothelial cells (VEcad^−/−^) were maintained in DMEM, 20% FBS, 1× endothelial cell growth supplement (ECGS), 100 mg/liter heparin, and 1× penicillin/streptomycin. HUVECs were obtained from the Yale tissue culture core, cultured in M199, 20% FBS, 1× ECGS, 100 mg/liter heparin, and 1× penicillin/streptomycin, and used at passage 1--6. ECGS was prepared by homogenizing and clarifying bovine hypothalamus (Pel-Freez Biologicals) as described previously ([@bib44]).

Antibodies and reagents
-----------------------

The following antibodies were used for immunoblotting throughout this study: rabbit anti-Flag (\#2368; Cell Signaling Technology) and goat anti-VEcad (C-19; Santa Cruz Biotechnology, Inc.). Total and phospho-VEGFRs were detected with rabbit anti-VEGFR2 (\#2479; Cell Signaling Technology), goat anti-HsVEGFR3 (AF349; R&D Systems), goat anti-MmVEGFR3 (AF743; R&D Systems), rabbit anti-VEGFR2^pY1175^ (\#2478; Cell Signaling Technology), rabbit anti-VEGFR^pY1054/9^ (44-1047G; Invitrogen), and rabbit anti-VEGFR3^pY1230/1^ (CY1115; Cell Applications). Other phospho-antibodies used for immunoblotting include rabbit anti-SFK^pY416^ (\#6943; Cell Signaling Technology), rabbit anti-p85^pY458^ (\#4228; Cell Signaling Technology), rabbit anti-Akt^pS473^ (700392; Invitrogen), and rabbit ant-p65^pS536^ (\#3033; Cell Signaling Technology). Anti--VCAM-1 was obtained from Abcam (ab134047). Loading control antibodies include rabbit anti--β-Actin (N-21; Santa Cruz Biotechnology, Inc.), rabbit anti-p85 (06-497; EMD Millipore), goat anti-HA (\#ab9134; Abcam), rabbit anti--β-Catenin (\#9562; Cell Signaling Technology), rabbit anti-GFP (A11122; Invitrogen), and mouse anti-Tubulin (DM1A; Sigma-Aldrich). Human VEGF-A165 was obtained from R&D Systems (293-VE-010).

Viral infection
---------------

Lentiviral expression plasmids were cotransfected with pVSVG and psPAX2 packaging plasmids into HEK-293T cells with Lipofectamine 2000 (Life Technologies). Viral supernatants were collected and used to infect VEcad^−/−^ cells in the presence of 10 µg/ml polybrene. 48 h after infection, cells were assayed for protein expression and subjected to cell panning on anti-VEcad--coated dishes or FACS sorting to enrich the infected population as necessary.

siRNAs
------

HUVECs were transferred into endothelial growth media (Lonza) for 24 h, then cells at ∼75% confluency were transfected with 10 nM final ON-Target Smartpool siRNAs (L-003138 and L-003148 from GE Healthcare; AM4636 from Ambion) complexed with RNAiMAX (Invitrogen). VEGFR2 siRNA, 5′-GGGCAUGUACUGACGAUUA-3′, 5′-CUACAUUGUUCUUCCGAUA-3′, 5′-GGAAAUCUCUUGCAAGCUA-3′, and 5′-GCGAUGGCCUCUUCUGUAA-3′; VEGFR3 siRNA, 5′-CGCCCGAGUUCCAGUGGUA-3′, 5′-GAACUUGACCGACCUCCUG-3′, 5′-GCGAAUACCUGUCCUACGA-3′, and 5′-GCAAGAACGAUCUGUU-3′. Cells were maintained in transfection media for 24 h, then returned to standard M199 base media. Experiments were performed 72--90 h after transfection. For adenoviral rescue, cells were infected with virus and 5 µg/ml polybrene 36 h after siRNA transfection.

Immunoprecipitation
-------------------

Confluent HUVECs in complete medium were rinsed with PBS containing 1 mM Ca^2+^ and 0.5 mM Mg^2+^, then lysed with cold 25 mM Tris, pH 7.5, 600 mM NaCl, 0.3% CHAPS (3023; Sigma-Aldrich), 0.15% Triton X-100, 1.5× PhosSTOP (Roche), and 1.5× Protease inhibitor (Roche) at 1 ml/10^6^ cells. Lysates were drawn through a 23G syringe 15 times and incubated on ice for 30 min before clarification at 20,000 *g* for 10 min. Clarified lysates were immunoprecipitated with either anti-Flag resin (Sigma-Aldrich) or Protein A/G beads (Santa Cruz Biotechnology, Inc.) bound to anti-cadherin (VEcad, BV9 \[Santa Cruz Biotechnology, Inc.\]; Ncad, 610920 \[BD\]) or VEGFR (VEGFR2, 55B11 \[Cell Signaling Technologies\]; VEGFR3, AF349 \[R&D Systems\]) antibodies, as indicated, for 2.5 h at 4°C. Beads were washed three times with 1 ml of lysis buffer. Flag immunoprecipitates were eluted at 4°C for 60 min in lysis buffer with 0.2 mg/ml 3×-flag peptide (Sigma-Aldrich). Eluted proteins were then collected in protein sample buffer (PSB), then analyzed by SDS-PAGE and immunoblotting with chemiluminescent HRP detection.

### p85 immunoprecipitation.

Cells were lysed in 25 mM Tris, pH 7.5, 200 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 1.5× PhosSTOP, and 1.5× Protease inhibitor for 30 min on ice before clarification at 20,000 *g*. Immunoprecipitation was performed with anti--p85-bound Protein A/G beads at 4°C for 6 h. Beads were then washed four times with 1 ml of lysis buffer, eluted in PSB, and analyzed by SDS-PAGE and immunoblotting with anti-p85 ^pY458^.

In vitro binding
----------------

Synthetic cDNAs encoding either Flag-tagged (cadherin) or HA-tagged (receptor tyrosine kinase) TMDs were constructed in a modified pET28 vector for bacterial expression. Flag-VE-TMD, MAAAAGSDYKDDDDKGCPGGNASVSIQAVVAILLCILTITVITLLIFLRRRSGGLNDIFEAQKIEWHESSEFEFEHHHHHH\*; Flag-N-TMD, MAAAAGSDYKDDDDKGCPGGNASGAIIAILLCIIILLILVLMFVVWMKRRSGGLNDIFEAQKIEWHESSEFEFEHHHHHH\*; HA-VEGFR2-TMD, MAAAAGSYPYDVPDYAGCPGGNASLEIIILVGTAVIAMFFWLLLVIILRTVKRRSGGDSLEFIASKLAGSEFEFEHHHHHH\*; HA-VEGFR3-TMD, MAAAAGSYPYDVPDYAGCPGGNASMEIVILVGTGVIAVFFWVLLLLIFCNMRRSGGDSLEFIASKLAGSEFEFEHHHHHH\*; HA-PDGFRβ-TMD, MAAAAGSYPYDVPDYAGCPGGNASLTVAAAVLVLLVIVIISLIVLVVIWKRSGGDSLEFIASKLAGSEFEFEHHHHHH\*. Asterisks indicate stop codons/C terminus. Constructs were transformed into BL21 cells. Cultures were expanded in super broth at 37°C before shifting to 30°C and inducing protein expression with 50 µM IPTG for 5 h. Bacteria were pelleted and frozen at −80°C. Pellets were resuspended in 50 mM Tris, pH 7.5, 150 mM NaCl, 0.1% CHAPS, 0.2% Triton X-100, 1× protease inhibitor, 0.25 mM DTT, 5 mM imidazole, and 1.5 mg/ml lysozyme, incubated on ice for 15 min, then sonicated three times with 30 500-ms pulses at 50% output. Lysates were clarified by centrifugation at 20,000 *g* for 20 min. Supernatants were incubated with Ni^2+^-NTA resin for 1 h at 4°C, then beads were washed four times and eluted for 2 h, at 4°C, with 300 mM imidazole. For each binding reaction, ∼1 µg of HA-tagged proteins were captured with Protein A/G resin, prebound with HA.11 monoclonal antibody (Covance). Resin was then washed and equilibrated in binding buffer containing 25 mM Tris, pH 7.5, 300 mM NaCl, 0.3% CHAPS, 0.15% Triton X-100, 0.25 mM DTT, and 1× protease inhibitor at 37°C. Then, eluted Flag-tagged cadherin TMD were diluted to 20 µg/ml in binding buffer, warmed to 37°C for 30 min, and clarified at 20,000 *g*. The HA-bound resin and Flag-tagged peptides were rotated at 37°C for 2.5 h, washed three times with 37°C binding buffer, and eluted in PSB. Blots were then performed with rabbit anti-Flag (CST) and goat anti-HA antibodies.

Shear stress alignment
----------------------

Cells were seeded on plastic-coated cell culture--treated slides with 10 µg/ml bovine fibronectin for ∼24 h, clamped into a 25 × 55 mm parallel plate flow chamber ([@bib21]), and sheared at 12 dynes/cm^2^ in complete media for 16 h. Cells were fixed in 3.7% formaldehyde and stained with either anti-Flag (2368; Cell Signaling Technology) or anti--VEcad (C19; Santa Cruz Biotechnology, Inc.), Alexa Fluor 647--phalloidin (Molecular Probes), and Hoechst (Molecular Probes). Slides were mounted in fluoromount-G (SouthernBiotech). Fluorescence microscopy was performed at room temperature with a microscope (80i; Nikon) equipped with 10× (NA 0.45) and 20× (NA 0.75) objective lenses and a CCD camera (Retiga 200R; QImaging). Images were collected throughout the length of the slide with NIS Elements software. Cells were then scored for alignment within ±23° of the axis of shear using ImageJ.

Oscillatory flow and monocyte adhesion
--------------------------------------

Reconstituted VEcad^−/−^ cells were starved in 2% FBS, 0.1× ECGS for 72 h. HUVEC were starved in 5% FBS, 0.25× ECGS for 8 h. Cells in parallel plate chambers were subjected to oscillatory shear at 1 ± 3 dynes/cm^2^ at 1 Hz for 18 h by applying flow from a motorized syringe pump (NE-1050; New Era) and a peristaltic pump (Microflex; Cole-Palmer), as described previously ([@bib54]). To assay monocyte adhesion, THP-1 suspension cultures were resuspended in HBSS, 1 mM Ca^2+^, 0.5 mM Mg^2+^, and 0.5% BSA, and added to the slides with HUVECs. After 30 min at 37°C, slides were washed four times in HBSS with cations and fixed with 3.7% formaldehyde. Cells were stained with anti--VEcad (C19; Santa Cruz Biotechnology, Inc.), phalloidin, and Hoechst before fluorescence microscopy. A 10× objective lens was used to capture 8--12 random images from the center of the slide and bound monocytes were counted per image. Data were normalized relative to siScrambled, and static and multiple independent experiments were used to obtain mean-fold changes with SEM.

Short-term shear
----------------

For shear \<60 min, cells were starved for 18 h in media containing 2% FBS, 0.1× ECGS, then exposed to 12 dynes/cm^2^ laminar shear for the indicated times. Cells were rinsed in PBS, snap-frozen at −80°C, and thawed into cold RIPA buffer, and lysates were clarified as before. For VEGFR activation, triplicate slides were combined for each time point.

Integrin activation assays
--------------------------

GST-FN9-11 in pGEX was induced in BL21 cells and purified according to standard procedures into TBS-Tween buffer. Protein was desalted to remove Tween and diluted to 20 µg/ml in TBS containing 0.5% BSA and either 1 mM Ca^2+^, 1 mM Mg^2+^, or 1 mM Mn^2+^. Starved cells were sheared at 12 dynes/cm^2^ for 15 min, rinsed, and incubated with GST-FN at 37°C for 30 min. Slides were washed in RT buffer three times for 5 min each with gentle agitation. Cells were then lysed in PSB, then analyzed by SDS-PAGE and immunoblotting for GST (\#2625; Cell Signaling Technology).

RNA isolation and qPCR
----------------------

Intimal RNA isolation was performed according to [@bib48]. In brief, C57BL/6 mice were euthanized and perfused with saline through the left ventricle. Aortic sections between the arch and thoracic region were isolated and cleared of periadventitial tissue before eluting the endothelium with 250 µl of QIAzol (QIAGEN) perfused through an insulin syringe. RNA from the endothelium and remaining media were then isolated and amplified with miRNeasy mini using whole transcriptome amplification kits (QIAGEN) according to the manufacturer's instructions. cDNA was then used for real-time quantitative PCR in a real-time PCR detection system (CFX96; Bio-Rad Laboratories) using iQ-SYBRGreen supermix (Bio-Rad Laboratories). VEGFR3 was amplified with QIAGEN primer set QT01744848. Other primers include SMA Fwd, ATCGTCCACCGCAAATGC; and Rev, AAGGAACTGGAGGCGCTG; SM22 Fwd, GCGCCTGGGCTTCCA, and Rev, CAGGCTGTTCACCAATTTGCT; VECAD Fwd, CACTGCTTTGGGAGCCTTC, and Rev, GGGGCAGCGATTCATTTTTCT; and B2M Fwd, CCGAGCCCAAGACCGTCTA, and Rev, AACTGGATTTGTAATTAAGCAGGTTCA. The normalized ratios of messages within the endothelial elutes from individual aortas were then quantified and graphed in Prism (GraphPad Software).

Vegfr3 reporter and deletion experiments
----------------------------------------

*Vegfr3::YFP* mice were created by homologous recombination of a BAC clone, modified by inserting YFP within exon 1 of a VEGFR3 allele, as previously described ([@bib3]). These mice have been backcrossed extensively with C57BL/6. To access *Vegfr3::YFP* expression, mice were sacrificed at 2--4 mo and fixed by perfusion with 3.7% formaldehyde. The aorta was removed, cleared of periadventitial tissue, and further fixed overnight at 4°C. Aortas were then embedded in paraffin and sectioned longitudinally by the Yale Pathology Tissue Microarray facility. *Vegfr3^flox/flox^* mice were created previously by targeting the exon/intron1 of the *Vegfr3* locus with a neomycin cassette bounded by loxP and frt sites and crossing mice with β-actin--driven FLPe recombinase ([@bib31]). These mice have been backcrossed extensively with C57BL/6. To generate endothelial-specific inducible *Vegfr3* knockout mice, *Vegfr3^flox/flox^* mice were crossed with *Cdh5^CreERT2^* mice ([@bib59]; [@bib69]). At 6--8 wk of age, *Vegfr3^flox/flox^* mice, with or without the Cre recombinase, were then injected intra-peritoneally with 2 mg tamoxifen (Sigma-Aldrich) prepared in peanut oil (Sigma-Aldrich) with 10% ethanol on five consecutive days. For ex vivo protein analysis, the aorta was dissected 1 wk after tamoxifen injection and cleared of connective tissue and adventitia. Proteins were extracted with a denaturating extraction buffer containing 9.5 M urea, 1% NP-40, 5% β-mercaptoethanol, 1% pharmalytes (pI: 3--10), and proteases inhibitors and clarified by 20,000 *g* centrifugation. For immunohistological analysis, mice were sacrificed 3 wk after Cre induction and aortas were collected. All experiments were approved by the Institutional Animal Care and Use Committee of Yale University.

Immunohistochemistry
--------------------

Paraffin was removed in xylene baths and sections were progressively rehydrated before antigen retrieval for 30 min at 95°C in citrate buffer (10 mM sodium citrate, 0.05% Tween, pH 6). Sections were then blocked for 30 min in StartingBlock (Thermo Fisher Scientific) and probed either with anti-GFP antibody (\#A11122 \[Invitrogen\], overnight at 4°C, 1:400), anti-fibronectin antibody (\#3648 \[Sigma-Aldrich\], 1 h at RT, 1:500), or anti-VCAM1 antibody (\#ab134047 \[Abcam\], overnight at 4°C, 1:400). Slides were washed three times in PBS-Tween, once in PBS, and stained with donkey anti--rabbit Alexa Fluor 647 secondary antibody for 1 h at RT, at 1:500. Slides were washed as before then mounted with Fluoromount G (Southern Biotech). Samples were imaged with a microscope (80i; Nikon) as described for the shear experiments. To quantify, 10× images were used to determine the mean fluorescence intensity of the endothelial layer of the inner and outer curvatures defined as signal at a depth of ∼15 µm from the lumen. Background signal was measured within the lumen and subtracted. The ratio of inner curvature/outer curvature per mouse was calculated and graphed using Prism.

Online supplemental material
----------------------------

Fig. S1 illustrates similar expression, junctional localization, and catenin binding of cadherin chimeras in reconstituted VEcad^−/−^ cells. Fig. S2 shows the negligible influence of shear stress in the stability of the mechanosensory complex and the similar binding characteristics of VEGFR2 as compared with binding of VEGFR3 shown in [Fig. 3 B](#fig3){ref-type="fig"}. Fig. S3 illustrates colocalization of VEcad with VEGFR3 in cells spread on Fc-VE^ECD^. Fig. S4 shows the responsiveness of VEcad-reconstituted cells to VEGF-A stimulation. VEcad^N-TMD^ reconstituted cells show a partial, time-dependent rescue of VEGFR2 activation. Fig. S5 shows the extent of VEGFR2/3 expression in the rescue experiments performed as part of [Fig. 6](#fig6){ref-type="fig"} and the blotting strategy used to determine relative expression levels of VEGFR paralogues. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201408103/DC1>.
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